Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma

NCT05128201 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Disease

Interventions

RADIATION: consolidative radiotherapy

Sponsor

Jiangxi Provincial Cancer Hospital